Monocyte-reactive human alloantibodies may be of importance in situations such as transfusion reactions and bone marrow and kidney transplantation. So far, only complement-binding monocyte-reactive antibodies can be detected with a cytotoxicity assay, No antiglobulin assays are yet available that also detect noncomplement-fixing monocyte-reactive antibodies. The binding of monomeric IgG with high affinity to the Fc receptor I (FcRI) on monocytes has severely hampered the development of such an assay until now. We report on the selective removal of the FcRI from monocytes to test human sera in a flow cytofluorometry assay for the presence of monocyte-reactive IgG alloantibodies. Selective downmodulation of FcRI was accomplished by incubating the cells with murine monoclonal antibodies against FcRI followed by a second incubation with goat-antimouse IgG polyclonal antibodies. With such modified cells, human complement-binding and noncomplement-binding IgG and IgM alloantibodies against polymorphic determinants of the HLA class I and II glycoproteins, the human monocyte antigen system and polymorphic antigenic determinants of the LFA complex, can be detected in a sensitive and reproducible manner. © 1991 by The American Society of Hematology.
CITATION STYLE
Kuijpers, R. W. A. M., Dooren, M. C., Von Dem Borne, A. E. G. K., & Ouwehand, W. H. (1991). Detection of human monocyte-reactive alloantibodies by flow cytometry after selective downmodulation of the Fc receptor I. Blood, 78(8), 2150–2156. https://doi.org/10.1182/blood.v78.8.2150.bloodjournal7882150
Mendeley helps you to discover research relevant for your work.